laura_goodliffe Profile Banner
Laura Goodliffe Profile
Laura Goodliffe

@laura_goodliffe

Followers
559
Following
4K
Media
94
Statuses
2K

McMaster Critical Care Fellow | QMED 2017 | DLSPH MPH | Cardiology | Crit Care | Epidemiology | MedEd | Scuba, puppies & motorcycles

Hamilton, Ontario
Joined April 2013
Don't wanna be here? Send us removal request.
@dan___kim
Dan Kim
1 year
Hot off the press in @CJEMonline! Our expert panel just tackled cardiac and lung #POCUS for our POCUS literature primer series. @CAEP_EUC @CAEP_Docs @GillianSheppar9 @TomJelic 🔗 https://t.co/r4gUX87FSb Check out the 🧵 below for our top 5 papers on cardiac & lung POCUS 👇
1
36
88
@CritCareReviews
Critical Care Reviews
2 years
@JonathanCaseyMD & @KevinGibbsMD summarise the #PREOXItrial, which they presented this morning at #CCR24 and was simultaneously published in @NEJM https://t.co/4Awp1u7axg @PCCRG
0
16
22
@CardiacTrials
Cardiac Trials
2 years
Hepatic vein Doppler 🔑 Findings 🔹Severe TR – systolic flow reversal 🔹Constriction – expiratory diastolic flow reversal 🔹Restriction (aka myocardial disease) – INSPIRATORY diastolic flow reversal Don’t ignore the hepatic veins #pocus #Echofirst
0
56
152
@IM_Crit_
IMCrit
2 years
ICU Extubation Tips: Let’s admit it. As intensivists, we will never be as good in airway management as our Anesthesia or Emergency Medicine colleagues are. They intubate many more pts than we do & some of them under very suboptimal conditions. So, we can never match their skills
56
406
2K
@SameerSharifMD
Sameer Sharif
2 years
💉Do you sedate acutely ill patients in the ER or ICU?💉 🏥Check out our Network Meta-Analysis examining the safety and efficacy of all IV procedural sedation agents used in the ED and ICU!🏥 Link: https://t.co/C52CPJxo9B See Below for a Summary of What We Found 🧵 (1/N):
3
50
133
@IM_Crit_
IMCrit
2 years
ICU hemodynamic secrets: Not every case of cardiogenic shock (CS) is born equal. In this 👇 beautiful study, the researchers analyzed data from 1959 CS patients from 2 international cohorts:
3
85
410
@Samir_Grover
Samir C. Grover, M.D.
2 years
How to doctor - a thread.
32
475
2K
@G_MarquisGravel
Guillaume Marquis-Gravel
2 years
It’s out! Delighted to introduce the new @SCC_CCS guidelines on #antiplatelet therapy, chaired by @BaineyKevin and I, with a group of 21 primary 🇨🇦 panelists. https://t.co/CYwbfnlyBy @ShamirMehta @ebelleycote @Ricky_Turgeon @Mtl_PlateletLab @brianpotter11 @Cardio_Girl
5
41
105
@ACCinTouch
American College of Cardiology
2 years
Independent predictors of ticagrelor discontinuation due to dyspnea included current smoking status, prior PCI, hypercholesterolemia, prior CABG, PAD, BMI ≥30 kg/m2, Asian race (lower risk), and age ≥65 years old (higher risk). Read more: https://t.co/5x7TguH3rp #JACCINT
0
9
35
@CardiacTrials
Cardiac Trials
2 years
Arrhythmia management in pregnancy 📚 Cardiac-centered #womenshealth
1
65
172
@IM_Crit_
IMCrit
2 years
For those of use who work in the ICU and, unlike our ED colleagues, rarely see a myocardial infarction (MI) on presentation, these are some important electrocardiographic (ECG) patterns to consider as life-threatening STEMI equivalents:
9
270
1K
@CardiacTrials
Cardiac Trials
2 years
~~ 🔑 Update: New 2023 Duke criteria for infective endocarditis ~~ Note changes (in bold): w/ new microbiology dx, imaging (CT and FDG PET), and inclusion of surgical inspection as a major clinical criterion 💥 #CardioTwitter
0
114
301
@JACCJournals
JACC Journals
2 years
#Clopidogrel monotherapy was assoc w/ better thrombotic & bleeding outcomes than #aspirin monotherapy, regardless of clinical risk & relative ischemia/bleeding risk in pts undergoing #PCI & 6-18 months of DAPT w/out clinical events. https://t.co/ljjqqJp3Iv #JACC #HOSTEXAM
4
93
255
@DebSiegal
Deborah Siegal
2 years
STRATUS Trial published @JAMA_current 🩸Cluster trial 25 ICUs >27,000 patients 🩸Switch to “small-volume” tubes that⬇️blood drawn for lab tests may⬇️RBC transfusion↔️effect on testing 🩸Available, cost-neutral, compatible with analyzers – will you switch? https://t.co/sTkJVyfrgS
11
47
156
@CASivaram1
Chittur Sivaram MD MACP MACC
2 years
#echofirst 💜 Simple tip for pericardial effusion echo. Often timing of RV diastolic collapse is ambiguous. Obtaining m-mode through RV with either MV or AV included helps confirm timing of RV wall collapse 💜 End of T wave could be used if they are not flat @Deya_AlkhatibMD
2
46
114
@WFMMD
William F McIntyre
2 years
Our work out today in @AnnalsofIM shows the importance of systematic follow up for patients with so-called “secondary” or “peri-operative” #AtrialFibrillation. 1 in 3 will have AF recurrence when assessed with 14 day Holter @McMasterU @PHRIresearch
@AnnalsofIM
Annals of Int Med
2 years
Patients with new-onset atrial fibrillation during hospitalization face a surprising 1 in 3 risk of AF recurrence within 1 year, according to a new study. Findings highlight importance of vigilant monitoring and care. https://t.co/s5sSDLUzaE #AtrialFibrillation #HeartHealth
4
20
56
@JACCJournals
JACC Journals
2 years
This largest single-center study of DCD vs. DBD heart transplant recipients demonstrates no difference in 1-year outcomes including survival, treated rejection, CAV and hospital readmission. https://t.co/qyPdmcuhwS #JACC #Hearttx #ACCHFT #ACCEarlyCareer #CardioTwitter
0
28
79
@laxswamy
Lakshman Swamy ([email protected])
2 years
I often teach the a few core principles of what makes ICU decision making different from treating what appears to be similar problems on the med-surg floors. Here are a few principles I emphasize, in no particular order...🧵
14
263
1K
@yourICM
Intensive Care Medicine
2 years
⚤ Sex & gender differences in #ICU, influence on 🏥 admission 🧫 #sepsis & septic shock 🫀 cardiac arrest 🫁 #ARDS 🫀 cardiogenic shock 🫘 #AKI 😵‍💫 delirium 🩺 medical treatment 🏥 general outcome Be aware & address in practice/research! #FOAMcc @yourICM 🔓 https://t.co/w8B010bn18
8
103
212
@ACCinTouch
American College of Cardiology
2 years
The 2023 ESC Guidelines for Management of Cardiomyopathies include all cardiomyopathy subtypes & mark the first time that specific recommendations are made for cardiomyopathies other than #cvHCM. Read the key points from the guideline here: https://t.co/kVqNvd5Pr7 #ESCCongress
Tweet card summary image
acc.org
Debabrata Mukherjee, MD, FACC
0
28
56